TR200101892T2 - Hafıza bozukluklarının tedavisi veya önlenmesi için fankuinonun kullanımı. - Google Patents

Hafıza bozukluklarının tedavisi veya önlenmesi için fankuinonun kullanımı.

Info

Publication number
TR200101892T2
TR200101892T2 TR2001/01892T TR200101892T TR200101892T2 TR 200101892 T2 TR200101892 T2 TR 200101892T2 TR 2001/01892 T TR2001/01892 T TR 2001/01892T TR 200101892 T TR200101892 T TR 200101892T TR 200101892 T2 TR200101892 T2 TR 200101892T2
Authority
TR
Turkey
Prior art keywords
prevention
treatment
fanquino
memory disorders
fanquinone
Prior art date
Application number
TR2001/01892T
Other languages
English (en)
Inventor
Nikolas Gerolymatos Panayotis
Xilinas Michel
Original Assignee
P.N. Gerolymatos S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by P.N. Gerolymatos S.A. filed Critical P.N. Gerolymatos S.A.
Publication of TR200101892T2 publication Critical patent/TR200101892T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

Hafiza bozuklugunun tedavisi veya önlenmesi için fankuinonun (4,7-fenantrolin- 5,6-dion) kullanimi tavsiye edilmektedir. Ayrica, normal bir kisinin ögrenme ve hafizani gelistirmek için bir yöntem de tavsiye edilmektedir, bahsedilen yöntem fankuinonun, opsiyonel olarak bir veya daha fazla farmasötik olarak uygun tasiyici ile birlikte uygulanmasini içerir.
TR2001/01892T 1999-01-07 2000-01-06 Hafıza bozukluklarının tedavisi veya önlenmesi için fankuinonun kullanımı. TR200101892T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR99100005 1999-01-07

Publications (1)

Publication Number Publication Date
TR200101892T2 true TR200101892T2 (tr) 2001-11-21

Family

ID=10943706

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01892T TR200101892T2 (tr) 1999-01-07 2000-01-06 Hafıza bozukluklarının tedavisi veya önlenmesi için fankuinonun kullanımı.

Country Status (17)

Country Link
US (1) US7030136B2 (tr)
EP (1) EP1140090B1 (tr)
JP (1) JP2002534386A (tr)
AR (1) AR022215A1 (tr)
AT (1) ATE285235T1 (tr)
AU (1) AU1792200A (tr)
BR (1) BR0008241A (tr)
CA (1) CA2358487C (tr)
DE (1) DE60016892T2 (tr)
DK (1) DK1140090T3 (tr)
ES (1) ES2234559T3 (tr)
HK (1) HK1042039B (tr)
IL (1) IL143903A (tr)
PT (1) PT1140090E (tr)
SI (1) SI1140090T1 (tr)
TR (1) TR200101892T2 (tr)
WO (1) WO2000040244A1 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ299739B6 (cs) 1997-08-21 2008-11-05 P. N. Gerolymatos S. A. Farmaceutický prostredek
AU2001250573A1 (en) * 2000-04-28 2001-11-12 Michel Xilinas Treatment of pathological conditions influenced by the action of matrix metalloproteinases (mmps) using phanquinone

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472257A (en) 1973-09-10 1977-05-04 Christiaens Sa A Derivative of 4-hydroxy-5-azacoumarin
IL84845A0 (en) * 1986-12-17 1988-06-30 Glaxo Group Ltd Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof
US5091391A (en) 1990-08-16 1992-02-25 University Of Pittsburgh Of The Commonwealth System Of Higher Education Method of resisting neurodegenerative disorders
DE69227380T3 (de) 1991-11-12 2007-01-11 Prana Biotechnology Ltd., South Melbourne Verfahren zur bestimmung und behandlung von alzheimer-krankheit
US5866597A (en) * 1993-03-19 1999-02-02 Glaxo Wellcome Inc. Use of triazine compounds for the treatment of memory and learning disorders
US5792774A (en) * 1996-02-21 1998-08-11 Chiroscience Limited Quinolones and their therapeutic use
WO1997046526A1 (en) 1996-06-07 1997-12-11 Eisai Co., Ltd. Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production
ES2162319T3 (es) 1996-08-13 2001-12-16 Gerolymatos P N Sa Uso del agente quelante clioquinol para la fabricacion de una composicion farmaceutica para el tratamiento de la enfermedad de alzheimer.
EP1007048A4 (en) 1997-03-11 2004-09-22 Gen Hospital Corp IDENTIFICATION OF AGENTS USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE
CZ299739B6 (cs) * 1997-08-21 2008-11-05 P. N. Gerolymatos S. A. Farmaceutický prostredek
US5980914A (en) 1997-08-22 1999-11-09 P.N. Gerolymatos S.A. Clioquinol for the treatment of Parkinson's disease
US5994323A (en) 1997-12-31 1999-11-30 P.N. Gerolymatos S.A. Pharmaceutical compositions comprising clioquinol in combination with vitamin B12 and therapeutic and prophylactic uses thereof

Also Published As

Publication number Publication date
AU1792200A (en) 2000-07-24
JP2002534386A (ja) 2002-10-15
SI1140090T1 (en) 2005-06-30
IL143903A (en) 2004-02-08
WO2000040244A1 (en) 2000-07-13
HK1042039B (zh) 2005-07-29
ATE285235T1 (de) 2005-01-15
DE60016892D1 (de) 2005-01-27
US7030136B2 (en) 2006-04-18
AR022215A1 (es) 2002-09-04
DK1140090T3 (da) 2005-04-18
US20030055078A1 (en) 2003-03-20
EP1140090B1 (en) 2004-12-22
CA2358487A1 (en) 2000-07-13
ES2234559T3 (es) 2005-07-01
CA2358487C (en) 2008-11-18
PT1140090E (pt) 2005-05-31
HK1042039A1 (en) 2002-08-02
EP1140090A1 (en) 2001-10-10
DE60016892T2 (de) 2005-12-15
BR0008241A (pt) 2001-10-30
IL143903A0 (en) 2002-04-21

Similar Documents

Publication Publication Date Title
EP2087892A3 (en) (S,S) reboxetine for treating age associated learning and mental disorders
CA2263561A1 (en) Thienopyrimidines
WO2001062290A3 (en) Methods and compositions for improving sleep
SE9503143D0 (sv) New preparation
LU91298I2 (fr) Pioglitazone en association avec la metformine et ses dérivés pharmaceutiquement acceptables-competact
GB0025173D0 (en) Therapeutic agents
GB9917406D0 (en) Compounds
TR200201322T2 (tr) H1 antagonistleri ve güvenli bir steroid'in göz sağlık koşullarının tedavisi için kullanımı
DK0739212T3 (da) Anvendelse af interleukin-12 til forebyggelse af transplantat-vs.-værtssygdom
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
BR0014381A (pt) Derivados de 5-beta-sapogenina e pseudossapogenina e seu uso no tratamento de demência
DE60001735D1 (de) 1-aminotriazolo 4,3-a chinazolin-5-one und/oder -thione inhibitoren von phosphodiesterasen iv
MY121864A (en) Condensed thienopyrimidines with phosphodiesterase-v inhibiting action.
AU7528001A (en) The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
NO993670D0 (no) Quinoksalin i trippelkombinasjon med proteaseinhibitorer og reverse transkriptaseinhibitorer som medikament for behandling av AIDS
PT946175E (pt) Utilizacao de uma combinacao de inibidores de h+, k+ -atpase e de glucocorticiodes no tratamento de polipos nasais
ITMI992107A0 (it) Uso del baclofen nel trattamento dell'astinenza da etanolo
NO960775L (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
NO984572D0 (no) Anvendelse av 2,5-dihydroksybenzensulfonderivater for fremstilling av legemidler ment for normalisering av den endoteliale funksjon, for behandling av seksuell dysfunksjon og vaskulµre komplikasjoner i diabetes, sÕvel som vaskulµre lidelser av e
TR200101892T2 (tr) Hafıza bozukluklarının tedavisi veya önlenmesi için fankuinonun kullanımı.
CA2228266A1 (en) Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs
FR2797399B1 (fr) Utilisation de la cyamemazine dans le traitement du sevrage aux benzodiazepines
DE68906245D1 (de) Therapeutisches mittel gegen aids.
BR9914722A (pt) Derivados de anticonvulsivo úteis no tratamento de dependência, vìcio e abuso do álcool